INR 19.0
(0.42%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 84.02 Million INR | 32.12% |
2022 | 63.6 Million INR | 295.74% |
2021 | 16.07 Million INR | -23.99% |
2020 | 21.14 Million INR | -21.48% |
2019 | 26.92 Million INR | 34.35% |
2018 | 20.04 Million INR | -30.87% |
2017 | 28.99 Million INR | -47.83% |
2016 | 55.57 Million INR | 23.65% |
2015 | 44.94 Million INR | 10.93% |
2014 | 40.51 Million INR | -0.16% |
2013 | 40.58 Million INR | 9.0% |
2012 | 37.23 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 6.57 Million INR | -89.45% |
2023 Q2 | 17.82 Million INR | 35.94% |
2023 Q3 | 4.49 Million INR | -74.76% |
2023 Q4 | 62.31 Million INR | 1285.28% |
2023 FY | 84.02 Million INR | 32.12% |
2023 Q1 | 13.11 Million INR | -44.34% |
2022 Q1 | 10.11 Million INR | 136.15% |
2022 Q2 | 15.23 Million INR | 50.59% |
2022 Q3 | 14.37 Million INR | -5.64% |
2022 Q4 | 23.55 Million INR | 63.81% |
2022 FY | 63.6 Million INR | 295.74% |
2021 FY | 16.07 Million INR | -23.99% |
2021 Q4 | -27.99 Million INR | -223.11% |
2021 Q3 | 22.73 Million INR | 73.2% |
2021 Q2 | 13.12 Million INR | 90.69% |
2021 Q1 | 6.88 Million INR | 291.23% |
2020 FY | 21.14 Million INR | -21.48% |
2020 Q4 | -3.59 Million INR | -135.24% |
2020 Q3 | 10.21 Million INR | -8.22% |
2020 Q2 | 11.13 Million INR | 116.56% |
2020 Q1 | 5.14 Million INR | 743.53% |
2019 Q1 | 4.06 Million INR | -64.85% |
2019 FY | 26.92 Million INR | 34.35% |
2019 Q4 | -798.72 Thousand INR | -107.54% |
2019 Q3 | 10.58 Million INR | -39.44% |
2019 Q2 | 17.48 Million INR | 329.74% |
2018 Q3 | 11.57 Million INR | 50.48% |
2018 Q2 | 7.69 Million INR | 0.0% |
2018 Q1 | 7.69 Million INR | -57.91% |
2018 FY | 20.04 Million INR | -30.87% |
2018 Q4 | 11.57 Million INR | 0.0% |
2017 Q3 | 18.27 Million INR | 142.96% |
2017 Q1 | 7.51 Million INR | 0.0% |
2017 Q2 | 7.51 Million INR | 0.0% |
2017 Q4 | 18.27 Million INR | 0.0% |
2017 FY | 28.99 Million INR | -47.83% |
2016 FY | 55.57 Million INR | 23.65% |
2015 FY | 44.94 Million INR | 10.93% |
2014 FY | 40.51 Million INR | -0.16% |
2013 FY | 40.58 Million INR | 9.0% |
2012 FY | 37.23 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | 85.509% |
Ind-Swift Limited | 946.56 Million INR | 91.123% |
Bajaj HealthCare Limited | 985.34 Million INR | 91.472% |
Sakar Healthcare Limited | 204.07 Million INR | 58.825% |
Aurobindo Pharma Limited | 55.65 Billion INR | 99.849% |
Innova Captab Limited | 931.03 Million INR | 90.975% |
Divi's Laboratories Limited | 14.17 Billion INR | 99.407% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 96.603% |
Morepen Laboratories Limited | 1.98 Billion INR | 95.772% |
Mankind Pharma Limited | 29.27 Billion INR | 99.713% |
Sequent Scientific Limited | 2.9 Billion INR | 97.104% |
Wanbury Limited | 978.96 Million INR | 91.417% |
Laurus Labs Limited | 11.9 Billion INR | 99.294% |
Nectar Lifesciences Limited | 932.7 Million INR | 90.991% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 99.278% |
Alembic Limited | 872.45 Million INR | 90.369% |
Hikal Limited | 4.46 Billion INR | 98.118% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 99.471% |
Neuland Laboratories Limited | 2.92 Billion INR | 97.132% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 99.432% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 99.821% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 96.182% |
Themis Medicare Limited | 1.12 Billion INR | 92.536% |
RPG Life Sciences Limited | 1.63 Billion INR | 94.862% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.933% |
Lupin Limited | 125.09 Billion INR | 99.933% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 95.987% |
Wockhardt Limited | 8.48 Billion INR | 99.009% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 97.267% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | 80.839% |
Jubilant Pharmova Limited | 14.45 Billion INR | 99.419% |
FDC Limited | 3.49 Billion INR | 97.599% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.912% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 79.626% |
Eris Lifesciences Limited | 4.94 Billion INR | 98.3% |
Venus Remedies Limited | 1.91 Billion INR | 95.615% |
ZIM Laboratories Limited | 1.01 Billion INR | 91.705% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 94.079% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -44.162% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 96.136% |
Shilpa Medicare Limited | 3.33 Billion INR | 97.48% |
Albert David Limited | 1.02 Billion INR | 91.811% |
Ajanta Pharma Limited | 30.46 Billion INR | 99.724% |
Hester Biosciences Limited | 908.84 Million INR | 90.754% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 94.01% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 96.71% |
Gufic Biosciences Limited | 1.18 Billion INR | 92.918% |
Windlas Biotech Limited | 1 Billion INR | 91.651% |
Procter & Gamble Health Limited | 2.99 Billion INR | 97.195% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -491.212% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | 48.203% |
Granules India Limited | 10.31 Billion INR | 99.185% |
Aarti Drugs Limited | 1.16 Billion INR | 92.803% |
Bal Pharma Limited | 555.62 Million INR | 84.877% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.744% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.946% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 92.177% |
Medicamen Biotech Limited | 335.16 Million INR | 74.929% |
Unichem Laboratories Limited | 6.72 Billion INR | 98.751% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | 81.556% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -1132.097% |
Valiant Laboratories Limited | 138.02 Million INR | 39.122% |
Orchid Pharma Limited | 800.77 Million INR | 89.506% |
Medico Remedies Limited | 59.67 Million INR | -40.811% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 96.044% |
Ipca Laboratories Limited | 18.98 Billion INR | 99.557% |
Brooks Laboratories Limited | 51.18 Million INR | -64.183% |
Syncom Formulations (India) Limited | 345.63 Million INR | 75.688% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.868% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.608% |
NATCO Pharma Limited | 10.05 Billion INR | 99.165% |
Suven Life Sciences Limited | 109.75 Million INR | 23.436% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -82.054% |
Strides Pharma Science Limited | 9.16 Billion INR | 99.083% |
Indoco Remedies Limited | 12.06 Billion INR | 99.303% |
Alpa Laboratories Limited | 127.38 Million INR | 34.033% |
Lasa Supergenerics Limited | 291.17 Million INR | 71.141% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 97.269% |